ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)

Technical Analysis Report for NYSE stock GSK Glaxosmithkline Plc. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange

If you are looking for Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc

Glaxosmithkline Plc Opened at 46.84 and Closed at: 46.54, which is -1.05% of previous session's close. It moved within a range of 46.33 and 47.21
The session was a Bearish session with an average volume of 2400570, which is -124.38% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.

A Dead cross was found 3 days back on short term averages

A Golden cross was found 8 days back on short term averages

Support for tomorrow is 46 and resistance for tomorrow is 46.88
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 46.18, 45.81 resistance for tomorrow's hourly charts is 47.06, 47.57

10 Day SMA for Glaxosmithkline Plc (GSK) is 48.73 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Glaxosmithkline Plc (GSK) is 49.17 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Glaxosmithkline Plc (GSK) is 50.53 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 51.01 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Glaxosmithkline Plc is 52.47 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Glaxosmithkline Plc is at 49.17 and 200 DMA is at 52.47, while 50 DMA and 100 DMA are at 50.53 and 51.01 respectively

Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 49.17 and 20 EMA is at 49.09

Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 50.53 and 50 EMA is at 50.11

Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 51.01 and 100 EMA is at 50.86

Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 52.47 and 200 EMA is at 50.26

Zoetis Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Zoetis Inc, about 1.2% more returns!

Centene Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Centene Corporation, about 3.7% more returns!

Glaxosmithkline Plc has performed better than Cvs Health in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc has performed better than Glaukos Corporation in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Globus Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Globus Medical, about 6.16% more returns!

Hca Healthcare has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Hca Healthcare, about 12.3% more returns!

Inspire Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Inspire Medical, about 17.98% more returns!

Glaxosmithkline Plc has performed better than Laboratory Corporation in short term. Holding Glaxosmithkline Plc could be a better choice for now!

3m Company has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in 3m Company, about 1.54% more returns!

Glaxosmithkline Plc has performed better than Merck Company in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Msa Safety has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Msa Safety, about 1.16% more returns!

Novartis Ag has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Novartis Ag, about 6.47% more returns!

Penumbra Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Penumbra Inc, about 3.45% more returns!

Pfizer Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Pfizer Inc, about 2.75% more returns!

Dr Reddy has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Dr Reddy, about 7.82% more returns!

Glaxosmithkline Plc has performed better than Unitedhealth Group in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc Technical analysis of indicators

Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Glaxosmithkline Plc in short term and the sell signal is strong.

Glaxosmithkline Plc Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Glaxosmithkline Plc in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Glaxosmithkline Plc is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 48.5 and Glaxosmithkline Plc GSK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.

Glaxosmithkline Plc Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And GSK Experts View which covers a lot of information including buying and selling signals

GSK future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here

Chart Glaxosmithkline Plc (GSK)  Technical (Analysis) Reports Glaxosmithkline Plc [

Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Glaxosmithkline Plc (GSK)  Technical (Analysis) Reports Glaxosmithkline Plc [

 

Back to top